超滤液-液质联用与分子对接筛选五味子参芪降糖颗粒中醛糖还原酶抑制剂
本研究以临床有效方剂参芪降糖颗粒(SJG)为对象,建立超滤液-液相色谱-质谱联用(UF-LC-MS)结合计算机分子对接的整合方法筛选醛糖还原酶抑制剂(ARIs)。从SJG中筛选出17个活性成分,其中人参皂苷Rd活性最强(IC50=45.77 μM),毛蕊异黄酮、戈米辛J和五味子甲素首次被证明为潜在抑制剂。
要点
- UF-LC-MS结合分子对接可高效筛选中药方剂中醛糖还原酶抑制剂。
- SJG中人参皂苷Rd对醛糖还原酶抑制活性最强(IC50=45.77 μM)。
- 毛蕊异黄酮、戈米辛J和五味子甲素首次被鉴定为醛糖还原酶抑制剂。
核心结论
- 具有临床疗效的中药方剂是筛选活性成分的希望来源。
- UF-LC-MS与分子对接联合是开发有效酶抑制剂的通用且有前景的方法。
研究设计与样本
- 实验研究:从兔晶状体中分离醛糖还原酶,以DL-甘油醛为底物,用紫外分光光度法检测抑制活性。
- 建立UF-LC-MS筛选方法并从SJG中筛选活性成分,结合分子对接理解结合机制。
主要发现
- 从SJG中筛选出17个活性成分。
- 人参皂苷Rd活性最强,IC50=45.77 μM。
- 毛蕊异黄酮、戈米辛J和五味子甲素的IC50分别为447.34 μM、181.73 μM和429.00 μM,均为首次证明。
- 多数活性化合物对醛糖还原酶表现为竞争性抑制。
- 皂苷类对接分数高于木脂素类,与验证结果一致。
关键数值与推荐
- 醛糖还原酶抑制活性以IC50表示:人参皂苷Rd为45.77 μM,毛蕊异黄酮为447.34 μM,戈米辛J为181.73 μM,五味子甲素为429.00 μM。
临床怎么用
- 提示SJG中多种成分具有醛糖还原酶抑制活性,可能与其治疗糖尿病并发症相关。
- UF-LC-MS联合分子对接可作为中药方剂中酶抑制剂筛选的候选方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Shenqi Jiangtang granule (SJG) is an ancient Chinese herbal formula used for treatment of Diabetes mellitus and its complications. AIM OF THE STUDY: To establish an integrated approach for discovery of effective Aldose reductase inhibitors (ARIs) from SJG. MATERIALS AND METHODS: An integrated approach combining ultrafiltration-liquid chromatography-mass spectrometry (UF-LC-MS) with in silico molecular docking was established for development of ARIs. AR enzyme was separated from the rabbit's crystalline lens. The inhibitory activities of these compounds were detected by UV spectrophotometry with DL-glyceraldehyde as a substrate. Furthermore, molecular docking was used to understand the binding mechanism of these screened compounds interacting with AR. RESULTS: After optimization of AR reaction system and ultrafiltration incubation system, 17 active ingredients were screened from SJG by UF-LC-MS technique. Among these potential AR inhibitors, ginsenoside Rd exhibited the strongest activity with IC50 value of 45.77 μM. Three of them, calycosin, gomisin J and schisandrin A were demonstrated to be potential inhibitors for the first time, with IC50 at 447.34 μM, 181.73 μM, and 429.00 μM, respectively. Most of the active compounds exhibited competitive inhibition against AR. The docking scores of saponins were higher than that of lignans, which was consistent with the verification results. CONCLUSION: The results indicated that TCM formula with clinical efficacy was indeed hopeful source for screening active ingredients, and the combination of UF-LC-MS and in silico molecular docking was a universal and promising approach for development of effective enzyme inhibitors.
引用
- Zhang H, Xu C, Tian Q, et al. Screening and characterization of aldose reductase inhibitors from Traditional Chinese medicine based on ultrafiltration-liquid chromatography mass spectrometry and in silico molecular docking. J Ethnopharmacol. 2020. PMID: 32890716. doi:10.1016/j.jep.2020.113282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。